AU3722593A - Compositions for the treatment of glaucoma - Google Patents

Compositions for the treatment of glaucoma

Info

Publication number
AU3722593A
AU3722593A AU37225/93A AU3722593A AU3722593A AU 3722593 A AU3722593 A AU 3722593A AU 37225/93 A AU37225/93 A AU 37225/93A AU 3722593 A AU3722593 A AU 3722593A AU 3722593 A AU3722593 A AU 3722593A
Authority
AU
Australia
Prior art keywords
glaucoma
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37225/93A
Inventor
William Cash
Marc De Gasparo
Peter Herold
Georg Mathis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU3722593A publication Critical patent/AU3722593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37225/93A 1992-02-17 1993-02-17 Compositions for the treatment of glaucoma Abandoned AU3722593A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH46192 1992-02-17
CH461/92 1992-02-17

Publications (1)

Publication Number Publication Date
AU3722593A true AU3722593A (en) 1993-09-03

Family

ID=4187547

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37225/93A Abandoned AU3722593A (en) 1992-02-17 1993-02-17 Compositions for the treatment of glaucoma

Country Status (4)

Country Link
AU (1) AU3722593A (en)
IL (1) IL104756A0 (en)
WO (1) WO1993015717A1 (en)
ZA (1) ZA931062B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100300566B1 (en) * 1994-09-17 2001-11-22 조생현 Pyrimidinone derivative and method for preparation thereof
FR2878522B1 (en) * 2004-12-01 2008-04-18 Merck Sante Soc Par Actions Si NEW SPECIFIC INHIBITORS OF CASPAS-10
EP1951071A2 (en) * 2005-10-18 2008-08-06 Artmed S.r.l. Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036048A (en) * 1986-03-07 1991-07-30 Schering Corporation Angiotensin II receptor blockers as antiglaucoma agents
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
CA2079344A1 (en) * 1990-03-30 1991-10-01 Eric E. Allen Substituted pyrimidines, pyrimidinones and pyridopyrimidines
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
WO1993015717A1 (en) 1993-08-19
ZA931062B (en) 1993-08-17
IL104756A0 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
AU2053597A (en) Pharmaceutical compositions for the treatment of glaucoma
AU3811193A (en) Cleansing compositions
AU4525396A (en) Process for the preparation of perfluorocarbons
AU650351B2 (en) Ophthalmic compositions
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU3263493A (en) Tonometer
AU1450392A (en) Small peptidic compounds useful for the treatment of glaucoma
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU3027692A (en) Compositions for the treatment of mammalian diseases
AU5526196A (en) Compositions for the treatment of dandruff
ZA931063B (en) Treatment of glaucoma.
AU5699396A (en) Compositions for the treatment of skin conditions
IL105285A0 (en) Compositions for the treatment of diabetes
IL103907A0 (en) Ophthalmic compositions
AU5371694A (en) Use of the tarchonanthus camphoratus
AU6301094A (en) The use of compositions for combating tumour diseases
AU4081393A (en) Medicaments for the treatment of anxiety
AU3722593A (en) Compositions for the treatment of glaucoma
AU5151093A (en) Process for the preparation of alkylglycosides
AU6662794A (en) Composition for the treatment of impaired hair growth
AU5018893A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AU5066693A (en) Process for the preparation of 5,6-diacetoxyindole
AU4676493A (en) Novel water treatment compositions